Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|October 27, 2016
Mechanisms of Resistance to Antibody-Drug ConjugatesFrank Loganzo, Matthew Sung, Hans-Peter Gerber
Journal of the American Chemical Society|December 15, 2005
Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agentsArie Zask, Joshua Kaplan, Sylvia Musto, et al.
Biochemical Pharmacology|December 22, 2015
Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?Hans-Peter Gerber, Puja Sapra, Frank Loganzo, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 19, 2013
Total syntheses and biological reassessment of lactimidomycin, isomigrastatin and congener glutarimide antibioticsKévin Micoine, Peter Persich, Josep Llaveria, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitrilesAllan Wissner, Philip R Hamann, Ramaswamy Nilakantan, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Tubulin inhibitors. Synthesis and biological activity of HTI-286 analogs with B-segment heterosubstituentsChuan Niu, Daniel Smith, Arie Zask, et al.
Biochemistry|November 19, 2003
Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubulesGirija Krishnamurthy, Wendy Cheng, Mei-Chu Lo, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2013
New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluationZecheng Chen, Andreas Maderna, Sai Chetan K Sukuru, et al.
Pageof 5